Soleno Therapeutics (SLNO) Change in Account Payables (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Change in Account Payables of -$3.0 million for Q1 2026, up 10.97% year-over-year from -$2.7 million in Q1 2025, and down 169.3% quarter-over-quarter from $4.3 million in Q4 2025.
Soleno Therapeutics (SLNO) Change in Account Payables (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Change in Account Payables for 14 consecutive years, with -$3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 10.97% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 257.3% YoY), while the FY2025 annual figure was $3.6 million, down 36.32% from the prior year.
- Change in Account Payables retreated to -$3.0 million in Q1 2026 per SLNO's latest filing, from $4.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.9 million in Q1 2024 and bottomed at -$4.3 million in Q2 2024.
- Historically, Change in Account Payables has averaged $365235.3 across 5 years, with a median of $198000.0 in 2022.
- On a YoY basis, Change in Account Payables climbed as much as 7482.35% in 2024 and fell as far as 733.92% in 2024.
- Soleno Therapeutics' Change in Account Payables stood at -$547000.0 in 2022, then soared by 106.22% to $34000.0 in 2023, then soared by 7482.35% to $2.6 million in 2024, then surged by 66.25% to $4.3 million in 2025, then plunged by 169.3% to -$3.0 million in 2026.
- Business Quant data shows SLNO's Change in Account Payables at -$3.0 million in Q1 2026, $4.3 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | -2.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.97 Mn |
| Mar 31, 2026 | -2.97 Mn |
| Dec 31, 2025 | 4.29 Mn |
| Dec 31, 2025 | 4.29 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 733,000.00 |
| Jun 30, 2025 | 733,000.00 |
| Mar 31, 2025 | -3.34 Mn |
| Mar 31, 2025 | -3.34 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | 4.87 Mn |
| Mar 31, 2024 | 4.87 Mn |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |